Precision Optics Corporation, Inc. (POCI)
Nasdaq · Healthcare · Medical Instruments & Supplies
$4.460.00%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $48.9M
- Forward P/E
- 148.7
- 52-week range
- $3.55 – $6.15
- 52-week change
- +6.19%
- EPS (trailing)
- −$0.43
- Analyst rating
- 1.0 Strong buy
- Next earnings
- Nov 12, 2026
Fiscal year to Jun 2026
- Revenue
- $31.5M (+65.17%)
- Net income
- −$3.6M
- Operating margin
- −11.1%
- Diluted EPS
- −$0.43
- Free cash flow
- −$2.0M
From the company’s annual report on SEC EDGAR.
About Precision Optics Corporation, Inc.
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.
Headquarters: Gardner, United States · 108 employees · poci.com